Search - tctmd.com

Displaying 141 - 160 of 204

Sort: Relevancy | Date

News Conference News AHA 2014

Biodegradable-Polymer DES Perform Well But Appear No Safer than Their Durable-Polymer Counterparts

November 18, 2014

News Daily News

OCT Study Suggests Plaque ‘Capping’ Safer With BRS Than BMS

November 06, 2014

News Industry News

Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent Following CE Mark

November 02, 2014

Presentation TCT 2014

TCT 576: Primary Endpoint Results From the PROMUS Element Plus US Postapproval Study (PE-Plus PAS): 1-Year Outcomes in Real-World Patients Treated with a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent

Presenter: John M. Lasala, Stuart J. Pocock, David E. Kandzari

September 16, 2014

Presentation TCT 2014

A New Thin-Strut, Low-Dose, Sirolimus-Eluting Stent With Abluminal-Only Biodegradable Polymeric Coating: Safety and Efficacy Clinical Performance of the Inspiron? Stent in___

Presenter: Guy F Prado Jr

September 16, 2014

News Conference News TCT 2014

Keynote Address Focuses on Newer DES, Problematic Subgroups

September 15, 2014

News Conference News TCT 2014

COMPARE II: BES, EES Show Similar Outcomes at Three Years

September 13, 2014

News Conference News ESC 2014

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Yael L. Maxwell

September 01, 2014

News Daily News

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

Yael L. Maxwell

July 03, 2014

News Industry News

PEACE I All Comers Registry Results Demonstrate Efficacy of BIOTRONIK Pulsar-18 Self-Expanding Stent

June 13, 2014

News Daily News

Nationwide Registry Shows Trends in DES Use Over a Decade

June 02, 2014

News Industry News

Svelte Medical Systems Announces Completion of 6-Month Follow-up in the DIRECT II Drug-Eluting Stent Study

May 29, 2014

News Industry News

Successful Live Case Demonstration of Elixir Medical’s CE Mark-Approved Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

May 21, 2014

News Industry News

Elixir Medical Corporation to Showcase a Live Case Demonstration of the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

May 14, 2014

News Industry News

Elixir Medical Receives CE Mark Approval for the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System

May 13, 2014

News Daily News

Autopsy Study Identifies Lesion, Procedural Traits Linked to Early Stent Thrombosis

April 23, 2014

News Daily News

Bioresorbable Scaffold Performs Well in Select STEMI Patients

January 22, 2014

News Industry News

Boston Scientific Receives FDA Approval For Promus Premier™ Everolimus-Eluting Platinum Chromium Coronary Stent System

November 24, 2013

News Industry News

MiStent SES Shown to be Unique in Clinical Setting

October 29, 2013

News Industry News

Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013

October 28, 2013

Advertisement

Biodegradable-Polymer DES Perform Well But Appear No Safer than Their Durable-Polymer Counterparts

OCT Study Suggests Plaque ‘Capping’ Safer With BRS Than BMS

Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent Following CE Mark

TCT 576: Primary Endpoint Results From the PROMUS Element Plus US Postapproval Study (PE-Plus PAS): 1-Year Outcomes in Real-World Patients Treated with a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent

A New Thin-Strut, Low-Dose, Sirolimus-Eluting Stent With Abluminal-Only Biodegradable Polymeric Coating: Safety and Efficacy Clinical Performance of the Inspiron? Stent in___

Keynote Address Focuses on Newer DES, Problematic Subgroups

COMPARE II: BES, EES Show Similar Outcomes at Three Years

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

PEACE I All Comers Registry Results Demonstrate Efficacy of BIOTRONIK Pulsar-18 Self-Expanding Stent

Nationwide Registry Shows Trends in DES Use Over a Decade

Svelte Medical Systems Announces Completion of 6-Month Follow-up in the DIRECT II Drug-Eluting Stent Study

Successful Live Case Demonstration of Elixir Medical’s CE Mark-Approved Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

Elixir Medical Corporation to Showcase a Live Case Demonstration of the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

Elixir Medical Receives CE Mark Approval for the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System

Autopsy Study Identifies Lesion, Procedural Traits Linked to Early Stent Thrombosis

Bioresorbable Scaffold Performs Well in Select STEMI Patients

Boston Scientific Receives FDA Approval For Promus Premier™ Everolimus-Eluting Platinum Chromium Coronary Stent System

MiStent SES Shown to be Unique in Clinical Setting

Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content